GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudeep Pharma Ltd
Sudeep Pharma Ltd sets July 23, 2026, as dividend record date
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 10 Jul 2026, 03:15 PM IST  ·  BSE ID: bac3fd8a-2dd9-405e-a42a-5a8daa2b73a4
View Original BSE Filing (PDF)
💡
In Simple Terms
Sudeep Pharma has set a date for deciding who gets its final dividend for the last financial year.
🤖 AI Summary
  • Sudeep Pharma Ltd fixed July 23, 2026, as the record date for FY 2025-26 final dividend.
  • The recommended final dividend is ₹1.50 per equity share of ₹1 face value.
  • Shareholder approval for the dividend is sought at the AGM on August 4, 2026.
  • Dividend payment is subject to tax deduction and shareholder approval.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹1.50
Face Value per Equity Share
₹1
Record Date
Thursday, 23rd July, 2026
AGM Date
Tuesday, 4th August, 2026
🏢 How This Affects the Company
💰
Financial Impact
The dividend payment will reduce the company's retained earnings upon approval and distribution.
⚠️
Risk Impact
Failure to secure shareholder approval at the AGM could prevent dividend distribution.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must ensure their shares are held in dematerialized form by close of business on July 23, 2026, to be eligible for the dividend.
👤
Who Is Affected
All beneficial owners of equity shares as of the close of business hours on Thursday, July 23, 2026, will be entitled to the dividend, subject to approval.
🔍
Management Signal
Management is signaling a return of capital to shareholders through a final dividend, pending AGM approval.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder approval at AGM on August 4, 2026.
Confirmation of dividend payment post-AGM approval.
FY26 Annual Report for detailed financial performance.
LOW RISK Standard dividend declaration process, dependent on AGM approval.
💡 Investor Takeaway
Sudeep Pharma Ltd has set July 23, 2026, as the record date for its recommended final dividend of ₹1.50 per equity share for FY 2025-26.
❓ Frequently Asked Questions
What is Sudeep Pharma's final dividend per share for FY 2025-26?
Sudeep Pharma has recommended a final dividend of ₹1.50 per equity share for the Financial Year 2025-26.
What is the record date for Sudeep Pharma's FY 2025-26 final dividend?
The record date for determining entitlement to the final dividend for FY 2025-26 is Thursday, July 23, 2026.
When will Sudeep Pharma's final dividend for FY 2025-26 be paid?
Payment of the dividend, if approved, will be made within the stipulated time period after the AGM on August 4, 2026.
What action is required from shareholders regarding Sudeep Pharma's dividend?
Shareholders need to ensure their shares are held in demat form by the close of business on July 23, 2026, to be eligible for the dividend.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.